Cat. No. | Product Name | Target | Signaling Pathways |
---|---|---|---|
T2369 |
Rociletinib
AVL-301,CNX-419,CO-1686 |
EGFR | Angiogenesis; JAK/STAT signaling; Tyrosine Kinase/Adaptors |
Rociletinib (CNX-419) 是一种可口服的EGFR 抑制剂,能够抑制 EGFRL858R/T790M 和 EGFRWT 的活性,IC50值分别为 21.5 nM 和 303.3 nM。 | |||
T14993 |
Rociletinib hydrobromide
AVL-301 hydrobromide,CO-1686 (hydrobromide),CNX-419 hydrobromide |
Others | Others |
Rociletinib hydrobromide is an orally delivered inhibitor of the mutant form of EGFR kinase (Kis: 21.5 nM and 303.3 nM for EGFR L858R/T790M and EGFR WT). |